STANDARD BIOTOOLS INC. — Director's Dealing 2020

Aug 25, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2020-08-20

Reporting Person: Linthwaite Stephen Christopher (President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-20	Common Stock	M	4750	—	Acquired	215609	Direct
2020-08-20	Common Stock	M	7813	—	Acquired	223422	Direct
2020-08-20	Common Stock	M	6882	—	Acquired	230304	Direct
2020-08-20	Common Stock	F	9791	$7.91	Disposed	220513	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-20	Restricted Stock Units	$	M	4750	Disposed		Common Stock (4750.0)	Direct
2020-08-20	Restricted Stock Units	$	M	7813	Disposed		Common Stock (7813.0)	Direct
2020-08-20	Restricted Stock Units	$	M	6882	Disposed		Common Stock (6882.0)	Direct

Footnotes

F1: Includes 4,613 shares purchased on May 31, 2020 under the Company's 2017 Employee Stock Purchase Plan.

F2: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F3: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units vesting as to 1/12th of the total number of shares on May 20, 2017, and as to 1/16th of the total number of shares each quarter thereafter.

F4: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter.

F5: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.